Skip to content
AnalystLens

Omega Healthcare Investors 8-K Report, Material Agreement (Jun 20, 2025)

Reports
Material Agreements·Financial Events·Exhibits & Filings
Filing Date
Filed June 20, 2025
Period End
June 20, 2025
Security
OHI
In the record · 2016–202610-K1210-Q348-K126

OHI filed 12 annual reports (10-K), 34 quarterly reports (10-Q) and 126 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · May ’17May ’17
  2. Material agreement8-K · Oct ’20Oct ’20
  3. Leadership change8-K · Jan ’23Jan ’23
  4. Leadership change8-K · Oct ’26Oct ’26

Summary

Summary of the 8-K filed June 20, 2025. Cited figures are marked; the original filing is the authoritative source.

On June 20, 2025, Omega Healthcare Investors, Inc. ("Omega") completed an underwritten public offering of $600 milliona aggregate principal amount of its 5.200% Senior Notes due 2030.

The Notes were sold at 99.118%b of principal amount, mature on July 1, 2030, and pay interest semi-annually on January 1 and July 1, beginning January 1, 2026. The offering was made under Omega's automatic shelf registration statement on Form S-3 (Registration No. 333-282376) and a related prospectus supplement. Omega expects to use the net proceeds for general corporate purposes, which may include repaying existing indebtedness, pursuing future acquisition or investment opportunities in healthcare-related real estate, and paying offering fees and expenses.

The Notes are unsecured senior obligations that rank equally with Omega's existing and future senior debt, are effectively subordinated to secured indebtedness to the extent of the collateral value, and are structurally subordinated to all liabilities of non-guarantor subsidiaries. They are guaranteed by OHI Healthcare Properties Limited Partnership and by future subsidiaries that guarantee unsecured debt of at least $100 millionc. The Indenture, with U.S. Bank Trust Company, National Association as trustee, includes covenants limiting additional indebtedness and mergers or asset sales, a covenant requiring a certain amount of unencumbered assets, and customary events of default, including cross-acceleration.

Omega may redeem the Notes before June 1, 2030 at par plus a make-whole premium, and at par plus accrued interest on or after that date. The filing was signed by Chief Financial Officer Robert O. Stephenson.

Key Highlights

  1. Omega issued $600 million of 5.200% Senior Notes due July 1, 2030 in an underwritten public offering completed June 20, 2025.
  2. The Notes were priced at 99.118% of principal amount.
  3. Interest is payable semi-annually on January 1 and July 1, starting January 1, 2026.
  4. The Notes are unsecured senior obligations, effectively subordinated to secured debt and structurally subordinated to non-guarantor subsidiary liabilities.
  5. OHI Healthcare Properties Limited Partnership guarantees the Notes, and future subsidiary guarantors are required when they guarantee at least $100 million of unsecured debt.
  6. Net proceeds are for general corporate purposes, including debt repayment and healthcare real estate acquisitions or investments.
  7. Redemption is available before June 1, 2030 at a make-whole price, and at par plus accrued interest on or after that date.

Frequently Asked Questions

  1. What did Omega Healthcare Investors issue?

    Omega completed an underwritten public offering of $600 million aggregate principal amount of 5.200% Senior Notes due 2030 on June 20, 2025.

  2. When do the Notes mature and how often is interest paid?

    The Notes mature on July 1, 2030. Interest is payable semi-annually on January 1 and July 1 of each year, beginning January 1, 2026.

  3. How will Omega use the proceeds?

    Omega expects to use the net proceeds for general corporate purposes, which may include repaying existing indebtedness, future healthcare-related real estate acquisitions or investments, and paying offering fees and expenses.

  4. What covenants and redemption rights apply to the Notes?

    The Indenture limits additional indebtedness and mergers or asset sales and requires maintaining a certain amount of unencumbered assets. Omega may redeem the Notes before June 1, 2030 at par plus a make-whole premium, and at par plus accrued interest on or after that date.

  5. How do the Notes rank relative to other Omega debt?

    The Notes rank equally with Omega's existing and future senior debt and senior to its subordinated debt. They are effectively subordinated to secured debt to the extent of collateral value and structurally subordinated to liabilities of non-guarantor subsidiaries.